Sio Gene Therapies Inc. Profile Avatar - Palmy Investing

Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize …

Biotechnology
US, New York [HQ]
Competitors · Subsidiaries · Locations

Business Intelligence

U.S. · Business Intelligence
Worldwide · Business Intelligence
End of SIOX's Analysis
CIK: 1636050 CUSIP: 829399104 ISIN: US8293991043 LEI: - UEI: -
Secondary Listings
SIOX has no secondary listings inside our databases.